ProQR Therapeutics NV (PRQR)
3.62
+0.01
(+0.28%)
USD |
NASDAQ |
Nov 22, 16:00
3.63
+0.01
(+0.28%)
After-Hours: 20:00
ProQR Therapeutics Max Drawdown (5Y): 97.50% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 97.50% |
September 30, 2024 | 97.50% |
August 31, 2024 | 97.50% |
July 31, 2024 | 97.50% |
June 30, 2024 | 97.50% |
May 31, 2024 | 97.50% |
April 30, 2024 | 97.50% |
March 31, 2024 | 97.50% |
February 29, 2024 | 97.50% |
January 31, 2024 | 97.50% |
December 31, 2023 | 97.50% |
November 30, 2023 | 97.50% |
October 31, 2023 | 97.50% |
September 30, 2023 | 97.50% |
August 31, 2023 | 97.50% |
July 31, 2023 | 97.50% |
June 30, 2023 | 97.50% |
May 31, 2023 | 97.50% |
April 30, 2023 | 97.50% |
March 31, 2023 | 97.50% |
February 28, 2023 | 97.50% |
January 31, 2023 | 97.50% |
December 31, 2022 | 97.50% |
November 30, 2022 | 97.50% |
October 31, 2022 | 97.50% |
Date | Value |
---|---|
September 30, 2022 | 97.50% |
August 31, 2022 | 97.50% |
July 31, 2022 | 97.50% |
June 30, 2022 | 97.50% |
May 31, 2022 | 97.50% |
April 30, 2022 | 96.91% |
March 31, 2022 | 96.00% |
February 28, 2022 | 95.40% |
January 31, 2022 | 88.80% |
December 31, 2021 | 88.80% |
November 30, 2021 | 88.80% |
October 31, 2021 | 88.80% |
September 30, 2021 | 88.80% |
August 31, 2021 | 88.80% |
July 31, 2021 | 88.80% |
June 30, 2021 | 88.80% |
May 31, 2021 | 88.80% |
April 30, 2021 | 88.80% |
March 31, 2021 | 88.80% |
February 28, 2021 | 88.80% |
January 31, 2021 | 88.80% |
December 31, 2020 | 88.80% |
November 30, 2020 | 88.80% |
October 31, 2020 | 88.80% |
September 30, 2020 | 88.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.80%
Minimum
Nov 2019
97.50%
Maximum
May 2022
93.51%
Average
97.20%
Median
Max Drawdown (5Y) Benchmarks
uniQure NV | 94.93% |
Merus NV | 67.42% |
argenx SE | 38.20% |
Pharming Group | -- |
Pharvaris NV | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -18.12 |
Beta (5Y) | 0.2568 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 101.5% |
Historical Sharpe Ratio (5Y) | -0.1459 |
Historical Sortino (5Y) | -0.2842 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.62% |